SCHEMBL6967069

SCHEMBL6967069

COc1ccc(CCc2cc(S(=O)(=O)S)ccc2C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
RAPGEF4 Q8WZA2 1/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
CA4 P22748 1/20 0.42
PKM P14618 2/20 0.42
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
BMP1 P13497 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
CA5A P35218 1/20 0.41
CA14 Q9ULX7 1/20 0.41
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10372349 0.86 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2RAPGEF4CA12CA1
SCHEMBL6963718 0.85 CHRM2 (0.47) CA1CA2CA9CA14
SCHEMBL6967077 0.84 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2RAPGEF4CA12CA1
SCHEMBL6604223 0.82 SFRP1 (0.43) ALDH1A1SMN1; SMN2CA12CA1CA2
SCHEMBL5008409 0.80 TUBB4A (0.51) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL6603744 0.76 IDH1 (0.43) POLB
SCHEMBL6603882 0.74 TDP1 (0.43) ALDH1A1SMN1; SMN2POLB
SCHEMBL6959646 0.74 TDP1 (0.43) ALDH1A1SMN1; SMN2POLB
SCHEMBL9559824 0.73 IDO1 (0.41) ALDH1A1SMN1; SMN2CA12CA9CA14
SCHEMBL13851197 0.73 PKM (0.67) ALDH1A1RAPGEF4CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed